Several companies are scheduled to be watched by primary market investors for initial public offerings (IPOs) this week. According to NDTV listings, investors have five IPOs to track during the week. The companies highlighted include Indo MIM, Lohia Corp, and Xtranet Technologies, with additional IPOs also mentioned in the combined weekly list. The reports present this as a week-specific roundup for primary market participants, pointing readers to details associated with each IPO. While the sources provided here do not include further specifics such as issue price, subscription dates, lot sizes, or listing timelines, they consistently frame the news as an IPO schedule update. Overall, the coverage focuses on alerting investors to the set of upcoming IPOs for the week, with Indo MIM, Lohia Corp, and Xtranet Technologies repeatedly named among the companies in the group.
Five companies file IPOs to watch this week: Indo MIM, Lohia Corp and others
Several companies are scheduled to be watched by primary market investors for initial public offerings (IPOs) this week. According to NDTV listings, investors have five IPOs to track during the week....
- NDTV reports that there are five IPOs to track this week in the primary market.
- The companies repeatedly listed include Indo MIM.
- Lohia Corp is included among the IPOs mentioned for the week.
- Xtranet Technologies is included among the IPOs mentioned for the week.
- The reporting is presented as a weekly IPO details roundup for investors.
Primary market investors will have five IPOs to track this week.
6 hours agoPrimary market investors will have five IPOs to track this week.
6 hours ago
Ericsson reports share buybacks for July 20–24, 2026
Telefonaktiebolaget LM Ericsson (publ) reports that it repurchases its own Class B shares during the period July 20 to J...
Sooryavanshi’s Zimbabwe knock reignites debate over Sanju Samson’s India T20I return
Vaibhav Sooryavanshi’s recent form in India’s T20I setup is renewing discussion around Sanju Samson’s return to the side...
AstraZeneca beats Q2 profit expectations and reiterates annual outlook
AstraZeneca reports stronger-than-expected second-quarter results and reiterates its annual guidance. In the three month...